Literature DB >> 13741103

Interaction of serum and sodium salicylate: changes during acute infection and its influence on pharmacological activity.

R C REYNOLDS, L E CLUFF.   

Abstract

Entities:  

Keywords:  BLOOD PROTEINS/chemistry; INFECTION/blood; SODIUM SALICYLATE/chemistry

Mesh：

Substances：

Year:  1960        PMID： 13741103

Source DB:  PubMed          Journal:  Bull Johns Hopkins Hosp        ISSN： 0097-1383


× No keyword cloud information.
  13 in total

1.  MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS.

Authors:  T F YUE; P G DAYTON; A B GUTMAN
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

2.  Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease.

Authors:  M S Roberts; R H Rumble; S Wanwimolruk; D Thomas; P M Brooks
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 3.  Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it.

Authors:  C Durnas; B J Cusack
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

4.  The effect of 3-methyl salicylic (O-cresotinic) acid on plasma insulin and glucose tolerance in diabetic and non-diabetic subjects.

Authors:  D E Hyams; A N Howard; I E Evans; S H Davison
Journal:  Diabetologia       Date:  1971-04       Impact factor: 10.122

5.  Monitoring plasma concentrations of salicylate.

Authors:  M Mandelli; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

6.  Clinical pharmacokinetics of salicylates: a re-assessment.

Authors:  G Levy
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

7.  Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.

Authors:  Z Trnavská; K Trnavský
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

8.  Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.

Authors:  P Netter; C Monot; M C Stalars; J M Mur; R J Royer; G Faure; J Pourel; J Martin; A Gaucher
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

9.  Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflammatory agent. I. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis.

Authors:  T M Chalmers; J E Pohl; D S Platt
Journal:  Ann Rheum Dis       Date:  1969-11       Impact factor: 19.103

Review 10.  Clinical pharmacokinetics of the salicylates.

Authors:  C J Needs; P M Brooks
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.